Lidocaine Base

Lidocaine base

Lidocaine base

Product Name: Lidocaine base

Synonyms: 2-(Diethylamino)-N-(2,6-dimethylphenyl)-acetamide; Lignocaine; 2-diethylaminoacet-2,6-xylidide; Lidocaine; Xylocaine; N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide; 2-[(2,6-dimethylphenyl)amino]-N,N-diethyl-2-oxoethanaminium

CAS Registry Number: 137-58-6

Assays: 99%

Packaging: 25kg/drum

Molecular Formula: C14H23N2O

Molecular Weight: 235.3447

EINECS: 205-302-8

Appearance: White crystal

discreet package alternate packaging

Payment Method:  Money Gram/Western Union T/T Company Account Bank

Package Safelyand Professionally Disguised Package Guaranteed. 1kg 500g 200g  100g  50g 20g 10g foil bag or tin

lead time:5 or 7 days 

Delivery Time: Within 24 hours after payment

Delivery : HKEMS, DHL, FEDEX, TNT

type： steroid powder or liquid

Production Capacity: 100 Kilograms Per Week 

Storage: Keep it under seal in cool and dark place

high successful delivery rate

High quality, best price, first-class service, high successful delivery rate 

The min. order is 10 grams.

Enterprise standard  

Usage:Lidocaine (INN, BAN) /ˈlaɪdɵkeɪn/, xylocaine, or lignocaine (AAN, former BAN) /ˈlɪɡnɵkeɪn/ is a common local anesthetic and class-1b antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning, and pain from skin inflammations, injected as a dental anesthetic, or used as a local anesthetic for minor surgery. It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic healthcare system

Topical lidocaine has been shown in some patients to relieve the pain of postherpetic neuralgia (a complication of shingles), though not enough study evidence exists to recommend it as a first-line treatment. Intravenous lidocaine also has uses as a temporary fix for tinnitus. Although not completely curing the disorder, it has been shown to reduce the effects by around two-thirds.[4][5]

Lidocaine is also the most important class-1b antiarrhythmic drug; it is used intravenously for the treatment of ventricular arrhythmias (for acute myocardial infarction, digoxin poisoning, cardioversion, or cardiac catheterization) if amiodarone is not available or contraindicated. Lidocaine should be given for this indication after defibrillation, CPR, and vasopressors have been initiated. A routine prophylactic administration is no longer recommended for acute cardiac infarction; the overall benefit of this measure is not convincing.